MARKET

MTFB

Motif Bio
MTFB
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-2.1344
-
-3.2311
50,966,896.26
UPDATE 2-Mexico's Televisa wins injunction on part of Disney-Fox deal; merger unaffected
MEXICO CITY, Dec 5- Mexican broadcaster Grupo Televisa won an injunction against Walt Disney Co's acquisition of Twenty-First Century Fox Inc's assets in Mexico, but Mexico's market regulator said on Thursday that the ruling would not stall the deal. Televisa
Reuters · 12/06/2019 03:03
UPDATE 1-Televisa wins injunction over Disney purchase of Fox assets in Mexico
MEXICO CITY, Dec 5- Mexican broadcaster Grupo Televisa has won a federal injunction against Walt Disney Co's acquisition of Twenty-First Century Fox Inc's assets in Mexico, a Televisa representative said on Thursday, a move that could at least temporarily stal
Reuters · 12/05/2019 20:32
Hedge fund titan Steve Cohen in talks to increase his stake in Mets
Hedge fund titan Steve Cohen in talks to increase stake in the New York Mets, his family office says.
CNBC.com · 12/04/2019 20:44
Mayor Pete is Hollywood's top pick now that Kamala Harris is out of the presidential race
Celebrities and entertainment executives have poured money into Pete Buttigieg's campaign, and he may be poised to benefit further after Kamala Harris dropped out.
CNBC.com · 12/04/2019 13:15
Investment guru Mellody Hobson: Financial illiteracy is 'dangerous' for society
Mellody Hobson, co-CEO and president of Ariel Investments, is a fierce advocate for financial literacy. Here's what she thinks needs to be done.
CNBC.com · 12/04/2019 13:00
The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 26)
Benzinga · 11/27/2019 12:26
The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Nov. 25.)
Benzinga · 11/26/2019 13:06
Motif Bio to file for voluntary delisting
Seeking Alpha - Article · 11/26/2019 12:41
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MTFB. Analyze the recent business situations of Motif Bio through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
50.00%Buy
50.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average MTFB stock price target is 3.500 with a high estimate of 5.00 and a low estimate of 2.000.
High5.00
Average3.500
Low2.000
Current 0.1050
EPS
Actual
Estimate
-0.06-0.04-0.03-0.01
Q1 2016
Q2 2016
Institutional Holdings
Institutions: 6
Institutional Holdings: 1.42M
% Owned: 0.29%
Shares Outstanding: 485.35M
TypeInstitutionsShares
Increased
2
34.84K
New
3
261.56K
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-2.71%
Pharmaceuticals & Medical Research
-0.51%
Key Executives
Non-Executive Chairman
Richard Morgan
Chief Executive Officer/Executive Director
Graham Lumsden
Chief Financial Officer/Non-Executive Director
Jonathan Gold
Vice President
Stephanie Noviello
Vice President
Rajesh Shukla
Executive Director
Robert Bertoldi
Other
David Huang
Secretary
Stephen Austin
Non-Executive Director
Craig Albanese
Non-Executive Director
Charlotta Ginman-Jones
Non-Executive Director
Zaki Hosny
Non-Executive Director
Mary Polan
No Data
  • All
  • Financials
  • Insiders
No Data

Webull offers kinds of Motif Bio stock information, including NASDAQ:MTFB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MTFB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MTFB stock methods without spending real money on the virtual paper trading platform.